June 27, 2019
Biosimilars – 2019 Mid-Year Update
- The U.S. biosimilars market: approvals, launches, and anticipated launches
- FDA guidance
- Select court cases and appellate guidance
- Trends in IPRs in the biosimilars space
- What’s on the horizon for biosimilars
Our hosts also review recent legislative proposals with potential impact on the biosimilars market.